about
Nucleotides in neuroregeneration and neuroprotectionRole of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptorAge-related nuclear translocation of P2X6 subunit modifies splicing activity interacting with splicing factor 3A1Synaptic terminals from mice midbrain exhibit functional P2X7 receptorP2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells.DREAM controls the on/off switch of specific activity-dependent transcription pathways.Diadenosine polyphosphate receptors. from rat and guinea-pig brain to human nervous system.Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models.PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions.Ectonucleotide pyrophosphatase/phosphodiesterase activity in Neuro-2a neuroblastoma cells: changes in expression associated with neuronal differentiation.In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases.Ca2+/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogenesis in neuroblastoma cells.Contribution of purinergic receptors to spinal cord injury repair: stem cell-based neuroregeneration.Presence of diadenosine polyphosphates in microdialysis samples from rat cerebellum in vivo: effect of mild hyperammonemia on their receptors.Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons.Reduced Mid1 Expression and Delayed Neuromotor Development in daDREAM Transgenic Mice.Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.Adenosine 5'-tetraphosphate (Ap(4)), a new agonist on rat midbrain synaptic terminal P2 receptors.Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.GABAB receptor-mediated presynaptic potentiation of ATP ionotropic receptors in rat midbrain synaptosomes.P2X7 receptors in rat brain: presence in synaptic terminals and granule cells.GABA modulates presynaptic signalling mediated by dinucleotides on rat synaptic terminals.Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.Axodendritic fibres of mouse cerebellar granule neurons exhibit a diversity of functional P2X receptors.Specific Temporal Distribution and Subcellular Localization of a Functional Vesicular Nucleotide Transporter (VNUT) in Cerebellar Granule Neurons.Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations.An Update on P2Y13 Receptor Signalling and Function.Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.Existence of high and low affinity dinucleotides pentaphosphate-induced calcium responses in individual synaptic terminals and lack of correlation with the distribution of P2X1-7 subunits.Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury.Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
P50
Q26781625-67915CEB-03C2-4FFB-BB4D-E1E7A9B3267BQ26824248-EC3A001B-F3A3-48A9-A5CF-E99FD67D9F53Q27310003-D9EB8AA6-D6C9-458F-B1BE-DE72EEC9F2A3Q28504863-E479C4DD-C4D8-464C-9565-4E83896D1CE9Q30499106-74FF3929-FCE5-4E2E-A5BD-38C23E735515Q33623164-0E6ADC6E-5DD2-4A3A-8EAB-D7FDF3A1849AQ34047309-5FE7CAA7-9732-483C-A4D3-BF6F5F103148Q37129336-8F66E78D-2C6D-4837-8F84-28ABC2E355CEQ38810232-278592A4-A4DA-4295-B4C8-A14E9E2F9809Q38982796-0DB8F744-F28B-47A2-987E-B36F2EEA8265Q39448933-AA0EB292-FC3D-42A8-A9DD-2475F4F8B114Q39812605-876D7697-1BA8-4C0A-980F-B3C438792C7AQ40080229-59393CEA-CD6D-44ED-B78B-66A58470B80EQ40121439-35C0C432-2BC3-4194-A4F2-46E7B57CDC16Q40348052-A3703FF9-DA71-4B61-9823-7A4F4449776BQ42144929-DDAC81EA-0A1B-447B-8778-CC7EF7D26C7BQ42722680-5042E430-16E5-4D67-8D49-2E84D260C9E9Q43506794-2A80F12F-B11F-4563-BBF6-ECBCF15DF481Q43543594-4AD0950A-5EC8-4F4B-8795-6DECE15CF55BQ44326772-72765573-FDF4-43B7-8B85-0B435B1D0EC3Q44626268-0376089C-B537-49D2-B64E-3AE20B09FA08Q44719370-9683DCDB-2C40-498D-BBAA-EF82037EA144Q45292466-91F16E0B-256E-4A29-BC58-093C7AAA5E50Q45949748-CB65BAAA-2DD5-4C09-B9F2-A707FAED8CBDQ47197276-C37C2EF1-0E98-44B0-98B5-C5B3BDE4F531Q47212302-90527965-96DE-43DA-BC28-CCECECDD4188Q47943130-73F7E644-C249-4A16-B659-2F14D7730C68Q48184328-9B80C4A0-B761-4143-8DC8-DF570F16CDBDQ48307184-6D509472-286B-40AC-AB87-9D40AB56505CQ48558365-816A6D28-4DCE-4487-B5E0-F3433A7CF51BQ48710631-E5C76586-0D8E-4969-B33A-B07431C672E6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rosa Gómez-Villafuertes
@ast
Rosa Gómez-Villafuertes
@en
Rosa Gómez-Villafuertes
@es
Rosa Gómez-Villafuertes
@nl
Rosa Gómez-Villafuertes
@sl
type
label
Rosa Gómez-Villafuertes
@ast
Rosa Gómez-Villafuertes
@en
Rosa Gómez-Villafuertes
@es
Rosa Gómez-Villafuertes
@nl
Rosa Gómez-Villafuertes
@sl
prefLabel
Rosa Gómez-Villafuertes
@ast
Rosa Gómez-Villafuertes
@en
Rosa Gómez-Villafuertes
@es
Rosa Gómez-Villafuertes
@nl
Rosa Gómez-Villafuertes
@sl
P1053
L-7181-2014
P106
P1153
6603084924
P21
P31
P3829
P496
0000-0002-7064-0906